'Supernanny' Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time T... (ts of child-rearing challenges. She has ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

'Supernanny' Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time To Talk(TM)

Date:10/11/2007

ts of child-rearing challenges. She has also has given her time to numerous charities on both sides of the Atlantic.

"I have seen children and parents interact and understand the balance of families, I want to make sure parents are equipped to help their children make healthy choices," said Frost. "I am pleased to have the opportunity to help the Partnership spread the word about this innovative campaign that helps equip parents and caregivers with the knowledge to safeguard their children from the risks of drug and alcohol abuse."

Time To Talk provides parents with practical tips, tools and information to not only start the conversation, but to keep it going. Parents can find helpful information on http://www.TimeToTalk.org such as -- Tips for Getting the Conversation Started, How to Help Your Kid Turn Down Drugs, a Drug Guide that highlighting the top 13 drugs teens use, answering the question: "Did You Do Drugs?" and "Is Your Child Using Drugs or Alcohol."

The Partnership for a Drug-Free America is a nonprofit organization uniting communications professionals, renowned scientists and parents. Best known for its national drug-education campaign, the Partnership's mission is to reduce illicit drug use in America. Now in its 20th year, the Partnership helps parents and caregivers effectively address drug and alcohol abuse with their children. A major new initiative now unfolding integrates the latest science and research with the most effective traditional media and digital communication techniques to give parents the tools, resources and support they need to help their children lead healthy lives. This effort -- the first ever for the Partnership -- will include a web-based interactive information resource center, parent-to-parent support network, a national toll-free call center and user-friendly online/offline tools. The Partnership depends on donations and support from individuals, corporati
'/>"/>

SOURCE The Partnership for a Drug-Free America
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Sadie Frost Takes a Swing on the Trapeze to Keep in Shape
2. Frostbite can Be Treated by Bloodclot Drug
3. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
4. Rat joins list of cloned animals
5. Richard Gere Joins Indian Stars For Fight Against AIDS
6. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
7. Anoushka Joins Hands With WFP to Feed the Poor
8. India Joins Hands With Global Body for Vaccine Research
9. Another Statewide Organization Joins the Fight Against Assisted Suicide
10. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
11. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Major New Study Finds Soyfoods Safe and Beneficial for Women With Breast Cancer 2 Health News:Macomb County Announces New Location for Four Upcoming H1N1 Clinics 2 Health News:American Association of Poison Control Centers: Treat Poinsettias and Mistletoe with Respect Rather Than Fear This Holiday Season 2 Health News:State $200 Million Behind in Payments to Agencies Providing Care to Thousands of Older Illinoisans 2 Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 2 Health News:Mechanism discovered by which body's cells encourage tuberculosis infection 3

[0] Major New Study Finds Soyfoods Safe and Beneficial for Women With Breast Cancer [0] Macomb County Announces New Location for Four Upcoming H1N1 Clinics [0] American Association of Poison Control Centers: Treat Poinsettias and Mistletoe with Respect Rather Than Fear This Holiday Season [0] State $200 Million Behind in Payments to Agencies Providing Care to Thousands of Older Illinoisans [0] Mechanism discovered by which body's cells encourage tuberculosis infection

Growth hormone is used to treat twice as many short boys than girls in the US and Asia Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower The Best Things in Life Are ... In Better Health & Living(R), A Free, Premium Magazine Launching April 26 in the Twin Cities U-M study: Work hassles hamper sleep Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 Arpida Provides Comprhensive Overview of Pivotal Phase III Trial Data

Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2 Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10 China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2 China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3 AMD LASERS Announces Partnerships With Three Industry Leading Companies 5686 1 Keryx Biopharmaceuticals Inc Announces Upcoming Poster Presentation of Zerenex 28ferric citrate 29 for the Treatment of Hyperphosphatemia at the Up 5683 1 Keryx Biopharmaceuticals Inc Announces Upcoming Poster Presentation of Zerenex 28ferric citrate 29 for the Treatment of Hyperphosphatemia at the Up 5683 2 Keryx Biopharmaceuticals Inc Announces Upcoming Poster Presentation of Zerenex 28ferric citrate 29 for the Treatment of Hyperphosphatemia at the Up 5683 3 Advanced Health Media Named to Deloittes 2009 Technology Fast 500 28TM 29 5680 1 Advanced Health Media Named to Deloittes 2009 Technology Fast 500 28TM 29 5680 2

[0] Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign [0] Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection [0] China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010

Other Medicine Technology:New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2 New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3 New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4 New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5 Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2 Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3 Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4 Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5 Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6 Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7

New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia

Medicine Products:

iRISystem AgileTrac™ Instrument Manager WatchMate MR RoamAlert Integrity Plus

'Supernanny' Jo Frost Joins the Partnership for a Drug-Free America in Supporting Time T...(ts of child-rearing challenges. She has ...),Health